[HTML][HTML] Molecular biology of osteosarcoma
AM Czarnecka, K Synoradzki, W Firlej, E Bartnik… - Cancers, 2020 - mdpi.com
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …
and the third most frequent in adults. Many inherited germline mutations are responsible for …
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
MJ Ramaiah, AD Tangutur, RR Manyam - Life sciences, 2021 - Elsevier
The role of genetic and epigenetic factors in tumor initiation and progression is well
documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA …
documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA …
Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy
D Zhi, T Yang, J Yang, S Fu, S Zhang - Acta biomaterialia, 2020 - Elsevier
Among various nanoparticles, superparamagnetic iron oxide nanoparticles (SPIONs) have
been increasingly studied for their excellent superparamagnetism, magnetic heating …
been increasingly studied for their excellent superparamagnetism, magnetic heating …
Bioinspired adhesive and tumor microenvironment responsive nanoMOFs assembled 3D-printed scaffold for anti-tumor therapy and bone regeneration
Y Jiang, X Pan, M Yao, L Han, X Zhang, Z Jia, J Weng… - Nano Today, 2021 - Elsevier
Tumor-induced bone loss is the main reason causing bone tumor therapy failure. Rational
design of implants with both anti-tumor and bone tissue regeneration functions is urgently …
design of implants with both anti-tumor and bone tissue regeneration functions is urgently …
[HTML][HTML] Mesenchymal stem cell derived exosomes as nanodrug carrier of doxorubicin for targeted osteosarcoma therapy via SDF1-CXCR4 axis
H Wei, F Chen, J Chen, H Lin, S Wang… - International journal …, 2022 - ncbi.nlm.nih.gov
Purpose The objective of this study was to investigate the antitumor activity, targeting
capability, and mechanism of the developed nanodrug consisting of doxorubicin and …
capability, and mechanism of the developed nanodrug consisting of doxorubicin and …
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
N Gaspar, R Venkatramani, S Hecker-Nolting… - The Lancet …, 2021 - thelancet.com
Background Tyrosine kinase inhibitors have shown activity in osteosarcoma and might
enhance the efficacy of chemotherapy. We aimed to determine the recommended phase 2 …
enhance the efficacy of chemotherapy. We aimed to determine the recommended phase 2 …
TP53 in bone and soft tissue sarcomas
E Thoenen, A Curl, T Iwakuma - Pharmacology & therapeutics, 2019 - Elsevier
Genomic and functional study of existing and emerging sarcoma targets, such as fusion
proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic …
proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic …
Chitosan-based biomaterials for the treatment of bone disorders
Bone is an alive and dynamic organ that is well-differentiated and originated from
mesenchymal tissues. Bone undergoes continuous remodeling during the lifetime of an …
mesenchymal tissues. Bone undergoes continuous remodeling during the lifetime of an …
Controlled delivery of curcumin and vitamin K2 from hydroxyapatite-coated titanium implant for enhanced in vitro chemoprevention, osteogenesis, and in vivo …
Successful repair of critical-sized tumor-resection defects, especially in load-bearing bones,
still remains a major challenge in clinical orthopedics. Titanium (Ti) implants have been …
still remains a major challenge in clinical orthopedics. Titanium (Ti) implants have been …
[HTML][HTML] The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a …
B Zhang, Y Zhang, R Li, J Li, X Lu, Y Zhang - Journal of Orthopaedic …, 2020 - Springer
Background Osteosarcoma, a primary malignant bone tumor derived from mesenchymal
tissue, is the most common type of pleomorphic tumor that occurs in children and …
tissue, is the most common type of pleomorphic tumor that occurs in children and …